Sudeep Pharma (SUDEEPPHRM) Share Price Falls 5% in Today’s Trade
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Sudeep Pharma Share Price fell 5% today to Rs 1,083.60, taking the company’s market capitalisation to Rs 13,560.61 crore. The move is relevant because the stock opened at Rs 1,197, touched the same level as the day’s high, and then moved lower to Rs 1,083.60, which also marked the day’s low. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the decline. In market-news terms, this is a clear Sudeep Pharma Share Price Today update and a factual Sudeep Pharma Stock News event that puts price action, valuation and sector context into focus for Univest readers.
For investors tracking Sudeep Pharma Share Price News, the immediate interest is in what changed during the session and what the numbers say about the stock’s standing. The company remains a Mid Cap name by the supplied category, and its current price now sits below the previous close of Rs 1,140.60 by Rs 57. This same-day decline also makes Sudeep Pharma Share Price Fall a useful entry point for a broader stock analysis, especially because the available fundamentals show a premium valuation profile versus the sector benchmark. Univest is presenting only verified data here, with no unconfirmed reason attached to the move.
Sudeep Pharma (SUDEEPPHRM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,083.6 |
| Previous Close | Rs 1,140.6 |
| Today's Move | -Rs 57.00 (-5%) |
| Open | Rs 1,197 |
| High | Rs 1,197 |
| Low | Rs 1,083.6 |
| Turnover | Rs 0.97 crore |
| Market Capitalisation | Rs 13,560.61 crore |
| Market Cap Category | Mid Cap |
Sudeep Pharma Share Price Today reflects a session that began at Rs 1,197, matched the day’s high at Rs 1,197, and then ended at Rs 1,083.60 after touching the day’s low at the same level. The stock lost Rs 57 from the previous close of Rs 1,140.60, which translates into a 5% decline. That makes today’s move a meaningful share price fall in absolute as well as percentage terms. The stock’s turnover stood at Rs 0.97 crore, which is a factual traded-value figure and not an explanation for the move. As a Mid Cap company, Sudeep Pharma Share Price has drawn attention from market followers looking for updated price action rather than assumptions about the cause. The verified data shows the extent of the decline clearly, while leaving the catalyst unresolved. For readers using Univest as a stock-market reference point, the next step is to connect this move with the company’s valuation and financial profile.
Sudeep Pharma (SUDEEPPHRM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 13,560.61 crore |
| P/E Ratio | 70.54x |
| P/B Ratio | 13.94x |
| ROE | 25.37% |
| ROCE | 28.5% |
| EPS | Rs 16.17 |
| Book Value Per Share | Rs 81.8 |
| Dividend Yield | 0.13% |
Sudeep Pharma carries a market capitalisation of Rs 13,560.61 crore, which places it in the Mid Cap category supplied for this event. The company’s P/E ratio is 70.54 and its P/B ratio is 13.94, both of which sit well above the healthcare sector benchmark medians of 31.74 and 3.02. That means the stock is valued at a premium to the same-industry benchmark on these two multiples. The ROE is 25.37% and ROCE is 28.5%, both above the benchmark medians of 11.78% and 13.65%, which points to stronger return metrics than the typical company in the comparison set. EPS stands at Rs 16.17, book value is Rs 81.8 per share, and dividend yield is 0.13%, giving a concise picture of earnings, accounting value and payout history. Univest notes these numbers as context, not as a forecast. In valuation terms, Sudeep Pharma Share Price is backed by profitability ratios that are higher than the sector medians, but the absolute multiples remain elevated relative to the benchmark universe.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 70.54x |
| Benchmark Median P/E | 31.74x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 13.94x |
| Benchmark Median P/B | 3.02x |
| Benchmark Average P/B | 4.44x |
| Company ROE | 25.37% |
| Benchmark Median ROE | 11.78% |
| Benchmark Average ROE | 11.19% |
| Company ROCE | 28.5% |
| Benchmark Median ROCE | 13.65% |
| Benchmark Average ROCE | 13.65% |
| Company Market Capitalisation | Rs 13,560.61 crore |
| Benchmark Median Market Cap | Rs 750.5 crore |
| Benchmark Average Market Cap | Rs 14,144.11 crore |
The company belongs to Healthcare and the Pharmaceuticals & Drugs industry, and the supplied sector snapshot uses the same industry as the benchmark scope across 200 companies. In that comparison set, Sudeep Pharma Share Price stands on a P/E of 70.54 versus the benchmark median of 31.74 and average of 47.98. Its P/B of 13.94 is also above the sector median of 3.02 and average of 4.44. On profitability, the company’s ROE of 25.37% is higher than the benchmark median of 11.78%, while ROCE of 28.5% is above the benchmark median and average of 13.65%. The sector data also shows market-cap context: benchmark median market cap is Rs 750.5 crore and average is Rs 14,144.11 crore, while Sudeep Pharma sits at Rs 13,560.61 crore. That places the company above the benchmark median and close to the benchmark average on size, with valuation ratios that are more demanding than the broader industry sample. Univest readers can use that contrast to understand why Sudeep Pharma Stock News is being watched closely after the day’s decline.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,957.5 | 36.4 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,47,576 | 83.41 | 13.81 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,233.01 | 84.58 | 20.55 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,670.55 | 24.29 | 4.07 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,272.68 | 32.62 | 3.13 | 11.83 | 16 |
Among the supplied listed peers, Sudeep Pharma Share Price sits alongside much larger healthcare companies such as Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla On market capitalisation, Sudeep Pharma at Rs 13,560.61 crore is below all five listed peers in the comparison set, which range from Rs 110,272.68 crore to Rs 441,957.5 crore. On valuation, its P/E of 70.54 is higher than Sun Pharma, Zydus, Cipla and Dr. Reddy’s style peer levels shown in the data, though below Divi’s Laboratories and Torrent Pharmaceuticals. Its P/B of 13.94 is above Sun Pharma, Zydus, Cipla and Dr. Reddy’s, and close to Divi’s Laboratories, but below Torrent Pharmaceuticals. The ROE of 25.37% and ROCE of 28.5% are also competitive against several peers, including Sun Pharma, Divi’s and Zydus. Univest’s peer view suggests the stock is not cheap on valuation, yet its return ratios are strong versus many listed comparables.
Why Investors Are Watching Sudeep Pharma
- The stock fell 5% today and closed at Rs 1,083.60 after ending at the day’s low.
- The previous close was Rs 1,140.60, while the session opened at Rs 1,197.
- Market capitalisation is Rs 13,560.61 crore, with the company placed in the Mid Cap category.
- P/E is 70.54 and P/B is 13.94, both above the sector benchmark medians.
- ROE is 25.37% and ROCE is 28.5%, both above the benchmark medians for the same industry.
About Sudeep Pharma
Sudeep Pharma operates in Healthcare and is classified in the Pharmaceuticals & Drugs industry. The supplied company information places it in the same industry that is used for benchmark comparison in this article. Univest is limiting this section to the verified sector and industry details provided in the workflow data. For readers following Sudeep Pharma Share Price, that means the company sits within a large and actively benchmarked pharmaceutical universe, with valuation and return ratios that can be compared directly with other listed names in the same industry. This is useful for Sudeep Pharma Share Price Today tracking, since today’s decline needs to be read alongside the company’s sector identity and financial metrics rather than in isolation.
Track Sudeep Pharma Share Price on Univest
Use Sudeep Pharma (SUDEEPPHRM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Sudeep Pharma Share Price live on Univest for the latest share price update, market cap, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers review stock news, financial analysis, peer comparison and company overview in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Sudeep Pharma Share Price fall today?
Ans. The data confirms a 5% decline in Sudeep Pharma Share Price to Rs 1,083.60, but it does not establish a company-specific catalyst. The move is therefore a verified price event, not a confirmed reason-led event.
What is Sudeep Pharma Share Price today?
Ans. Sudeep Pharma Share Price today is Rs 1,083.60. It is lower than the previous close of Rs 1,140.60 and below the opening price of Rs 1,197, according to the supplied market data.
How much did Sudeep Pharma Stock fall in today’s session?
Ans. Sudeep Pharma Stock fell Rs 57 in today’s trade, which equals a 5% decline. The day’s high and opening price were both Rs 1,197, while the low and close were Rs 1,083.60.
What is the market cap of Sudeep Pharma?
Ans. Sudeep Pharma has a market capitalisation of Rs 13,560.61 crore. The supplied category places it in the Mid Cap group, which is useful context for reading today’s Sudeep Pharma Share Price move.
How does Sudeep Pharma compare with the sector benchmark?
Ans. Sudeep Pharma trades at a P/E of 70.54 and P/B of 13.94, both above the sector medians of 31.74 and 3.02. Its ROE of 25.37% and ROCE of 28.5% are also above benchmark medians.
How does Sudeep Pharma compare with peers on valuation?
Ans. Compared with listed peers such as Sun Pharma, Divi’s, Torrent, Zydus and Cipla, Sudeep Pharma has a higher P/E than several names and a market cap below all the supplied peer companies in the comparison set.
